L. plantarum and L. lactis as a promising agent in treatment of inflammatory bowel disease and colorectal cancer

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Shen Q, Xu B, Wang C, Xiao Y, Jin Y. Bacterial membrane vesicles in inflammatory bowel disease. Life Sci. 306, 120803 (2022).
  Medline CASGoogle Scholar
• 2. Smillie CS, Biton M, Ordovas-Montanes J et al. Intra-and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178(3), 714–730; e722 (2019).
  Medline CASGoogle Scholar
• 3. Zheng J, Wittouck S, Salvetti E et al. A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int. J. System. Evolut. Microbiol. 70(4), 2782–2858 (2020).
  Medline CASGoogle Scholar
• 4. Gaenzle MG. Lactic metabolism revisited: metabolism of lactic acid bacteria in food fermentations and food spoilage. Curr. Opin. Food Sci. 2, 106–117 (2015).
  Google Scholar
• 5. Braat H, Rottiers P, Hommes DW et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4(6), 754–759 (2006).
  Medline CASGoogle Scholar
• 6. Vermeire S, Rutgeerts PJ, D'haens GR et al. A phase 2a randomized placebo-controlled double-blind multi-center dose escalation study to evaluate the safety, tolerability, pharmacodynamics and efficacy of AG011 in patients with moderately active ulcerative colitis. Gastroenterology 138(5), S9 (2010).
  Google Scholar
• 7. Madigan MT, Martinko J. Brock Biology of Microorganisms (11th Ed.). Prentice Hall, USA (2005).
  Google Scholar
• 8. Kleerebezem M, Boekhorst J, Van Kranenburg R et al. Complete genome sequence of Lactobacillus plantarum WCFS1. Proc. Natl Acad. Sci. USA 100(4), 1990–1995 (2003).
  Medline CASGoogle Scholar
• 9. Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science 308(5728), 1635–1638 (2005).
  MedlineGoogle Scholar
• 10. Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285), 59–65 (2010).
  Medline CASGoogle Scholar
• 11. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489(7415), 231–241 (2012).
  Medline CASGoogle Scholar
• 12. Górska A, Przystupski D, Niemczura MJ, Kulbacka J. Probiotic bacteria: a promising tool in cancer prevention and therapy. Current Microbiol. 76, 939–949 (2019).
  Medline CASGoogle Scholar
• 13. Zheng DW, Li RQ, An JX et al. Prebiotics-encapsulated probiotic spores regulate gut microbiota and suppress colon cancer. Adv. Mater. 32(45), 2004529 (2020).
  CASGoogle Scholar
• 14. Schwabe RF, Tabas I, Pajvani UB. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158(7), 1913–1928 (2020).
  Medline CASGoogle Scholar
• 15. Cremon C, Barbaro MR, Ventura M, Barbara G. Pre-and probiotic overview. Curr. Opin. Pharmacol. 43, 87–92 (2018).
  Medline CASGoogle Scholar
• 16. Shida K, Nanno M. Probiotics and immunology: separating the wheat from the chaff. Trends Immunol. 29(11), 565–573 (2008).
  Medline CASGoogle Scholar
• 17. O'flaherty S, Saulnier D, Pot B, Versalovic J. How can probiotics and prebiotics impact mucosal immunity? Gut Microbes 1(5), 293–300 (2010).
  MedlineGoogle Scholar
• 18. Shamekhi S, Lotfi H, Abdolalizadeh J, Bonabi E, Zarghami N. An overview of yeast probiotics as cancer biotherapeutics: possible clinical application in colorectal cancer. Clin. Translat. Oncol. 22, 1227–1239 (2020).
  Medline CASGoogle Scholar
• 19. Rawi MH, Zaman SA, Pa'ee KF, Leong SS, Sarbini SR. Prebiotics metabolism by gut-isolated probiotics. J. Food Sci. Technol. 57(8), 2786–2799 (2020).
  MedlineGoogle Scholar
• 20. Bedada TL, Feto TK, Awoke KS, Garedew AD, Yifat FT, Birri DJ. Probiotics for cancer alternative prevention and treatment. Biomed. Pharmacother. 129, 110409 (2020).
  MedlineGoogle Scholar
• 21. Denkova R, Goranov B, Teneva D, Denkova Z, Kostov G. Antimicrobial activity of probiotic microorganisms: mechanisms of interaction and methods of examination. Antimicrobial Research: Novel Bioknowledge and Educational Programs (1st Ed.). Méndez-Vilas A (Ed.). Formatex Research Center, S.L, Spain, 102–112 (2017).
  Google Scholar
• 22. Lavermicocca P, Valerio F, Evidente A, Lazzaroni S, Corsetti A, Gobbetti M. Purification and characterization of novel antifungal compounds from the sourdough Lactobacillus plantarum strain 21B. Appl. Environ. Microbiol. 66(9), 4084–4090 (2000).
  Medline CASGoogle Scholar
• 23. Neal-Mckinney JM, Lu X, Duong T et al. Production of organic acids by probiotic lactobacilli can be used to reduce pathogen load in poultry. PLOS ONE 7(9), e43928 (2012).
  Medline CASGoogle Scholar
• 24. Modler HW. Bifidobacteria and bifidogenic factors. Can. Inst. Food Sci. Technol. J. 23, 29–41 (1990).
  CASGoogle Scholar
• 25. Taylor TM, Rolfjoerger EP, Lopez-Malo A, Avila-Sosa R, Calix-Lara T. Alternatives to traditional antimicrobials for organically processed meat and poultry. In: Organic Meat Production and Processing (Edition: 1st) (Chapter: 13). Ricke SCVan Loo EJJohnson MGO'Brien CA (Eds). Wiley and Sons, Inc., 211–237 (2012).
  Google Scholar
• 26. Rowland IR, Capurso L, Collins K et al. Current level of consensus on probiotic science –report of an expert meeting-London, 23 November 2009. Gut Microbes 1(6), 436–439 (2010). https://doi.org/10.4161/gmic.1.6.13610
  MedlineGoogle Scholar
• 27. Ducrotté P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J. Gastroenterol. 18(30), 4012 (2012).
  Medline CASGoogle Scholar
• 28. Mcfarland LV. Probiotics for the primary and secondary prevention of C. difficile infections: a meta-analysis and systematic review. Antibiotics 4(2), 160–178 (2015).
  CASGoogle Scholar
• 29. Aggarwal S, Upadhyay A, Shah D, Teotia N, Agarwal A, Jaiswal V. Lactobacillus GG for treatment of acute childhood diarrhoea: an open labelled, randomized controlled trial. Indian J. Med. Res. 139(3), 379 (2014).
  MedlineGoogle Scholar
• 30. Mirnejad R, Vahdati AR, Rashidiani J, Erfani M, Piranfar V. The antimicrobial effect of Lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro. Iran. Red Crescent Med. J. 15(2), 122 (2013).
  MedlineGoogle Scholar
• 31. Javid H, Karimi-Shahri M, Khorramdel M, Sathyapalan T, Afshari A, Sahebkar A. Probiotics as an adjuvant for management of gastrointestinal cancers through their anti-inflammatory effects: a mechanistic review. Curr. Medicinal Chem. 30(4), 390–406 (2022). • This paper explores how probiotics can support the treatment of gastrointestinal cancers by reducing inflammation.
  Google Scholar
• 32. Kumar M, Dhaka P, Vijay D et al. Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli. Int. J. Antimicrob. Agents 48(3), 265–270 (2016).
  Medline CASGoogle Scholar
• 33. Perin L, Miranda R, Camargo A, Colombo M, Carvalho A, Nero L. Antimicrobial activity of the nisin Z producer Lactococcus lactis subsp. lactis Lc08 against Listeria monocytogenes in skim milk. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 65(5), 1554–1560 (2013).
  CASGoogle Scholar
• 34. Cosentino S, Fadda ME, Deplano M, Melis R, Pomata R, Pisano MB. Antilisterial activity of nisin-like bacteriocin-producing Lactococcus lactis subsp. lactis isolated from traditional Sardinian dairy products. BioMed Res. Int. 2012, 8 (2012).
  Google Scholar
• 35. Ivana S, Cvetanović D, Kojić M, Fira Đ, Maja T, Topisirović L. Characterization and antimicrobial activity of natural isolate Lactococcus lactis subsp. lactis BGSM1-19. Acta Veterinaria 57(5), 509–521 (2007).
  Google Scholar
• 36. Kitching M, Mathur H, Flynn J et al. A live bio-therapeutic for mastitis, containing Lactococcus lactis DPC3147 with comparable efficacy to antibiotic treatment. Front. Microbiol. 10, 2220 (2019).
  MedlineGoogle Scholar
• 37. Malvisi M, Stuknytė M, Magro G et al. Antibacterial activity and immunomodulatory effects on a bovine mammary epithelial cell line exerted by nisin A-producing Lactococcus lactis strains. J. Dairy Sci. 99(3), 2288–2296 (2016).
  Medline CASGoogle Scholar
• 38. Pathmakanthan S, Li CK, Cowie J, Hawkey CJ. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J. Gastroenterol. Hepatol. 19(2), 166–173 (2004).
  MedlineGoogle Scholar
• 39. Kim HG, Lee SY, Kim NR et al. Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation. Mol. Immunol. 48(4), 382–391 (2011).
  Medline CASGoogle Scholar
• 40. Scaldaferri F, Gerardi V, Lopetuso LR et al. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. BioMed Res. Int. 2013, 435268 (2013).
  MedlineGoogle Scholar
• 41. Xia Y, Chen HQ, Zhang M, Jiang YQ, Hang XM, Qin HL. Effect of Lactobacillus plantarum LP-Onlly on gut flora and colitis in interleukin-10 knockout mice. J. Gastroenterol. Hepatol. 26(2), 405–411 (2011).
  Medline CASGoogle Scholar
• 42. Chen H, Xia Y, Zhu S et al. Lactobacillus plantarum LP-Onlly alters the gut flora and attenuates colitis by inducing microbiome alteration in interleukin-10 knockout mice. Mol. Med. Reports 16(5), 5979–5985 (2017).
  Medline CASGoogle Scholar
• 43. Liu Z, Zhang P, Ma Y et al. Lactobacillus plantarum prevents the development of colitis in IL-10-deficient mouse by reducing the intestinal permeability. Mol. Biol. Reports 38(2), 1353–1361 (2011).
  Medline CASGoogle Scholar
• 44. Ahrne S, Johansson Hagslatt M-L. Effect of lactobacilli on paracellular permeability in the gut. Nutrients 3(1), 104–117 (2011).
  Medline CASGoogle Scholar
• 45. Lee B, Lee J-H, Lee H-S et al. Glycosaminoglycan degradation-inhibitory lactic acid bacteria ameliorate 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice. J. Microbiol. Biotechnol. 19(6), 616–621 (2009).
  Medline CASGoogle Scholar
• 46. Liu Y-W, Su Y-W, Ong W-K, Cheng T-H, Tsai Y-C. Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities. Int. Immunopharmacol. 11(12), 2159–2166 (2011).
  Medline CASGoogle Scholar
• 47. Duary RK, Bhausaheb MA, Batish VK, Grover S. Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol. Biol. Reports 39(4), 4765–4775 (2012).
  Medline CASGoogle Scholar
• 48. Karimi-Shahri M, Khorramdel M, Zarei S, Attarian F, Hashemian P, Javid H. Glioblastoma, an opportunity T cell trafficking could bring for the treatment. Mol. Biol. Reports 49(10), 9863–9875 (2022).
  Medline CASGoogle Scholar
• 49. Schultz M, Veltkamp C, Dieleman LA et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 8(2), 71–80 (2002).
  MedlineGoogle Scholar
• 50. Yin X, Heeney D, Srisengfa Y, Golomb B, Griffey S, Marco M. Bacteriocin biosynthesis contributes to the anti-inflammatory capacities of probiotic Lactobacillus plantarum. Beneficial Microbes 9(2), 333–344 (2018).
  Medline CASGoogle Scholar
• 51. Van Veen B, Pajander J, Zuurman K et al. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets. Eur. J. Pharmaceut. Biopharmaceut. 61(3), 149–157 (2005).
  Medline CASGoogle Scholar
• 52. Zhu D, Liu F, Xu H et al. Isolation of strong constitutive promoters from Lactococcus lactis subsp. lactis N8. FEMS Microbiol. Lett. 362(16), fnv107 (2015).
  MedlineGoogle Scholar
• 53. Kuipers O, Beerthuyzen M, De Ruyter P. Luesink EJ de Vos, WM Autoregulation of nisin biosythesis in Lactococcus lactis bysignal transduction. J. Biol. Chem. 270, 27299–27304 (1995).
  Medline CASGoogle Scholar
• 54. Pontes DS, De Azevedo MSP, Chatel J-M, Langella P, Azevedo V, Miyoshi A. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Prot. Express. Purificat. 79(2), 165–175 (2011).
  Medline CASGoogle Scholar
• 55. Steidler L, Rottiers P, Coulie B. Actobiotics™ as a novel method for cytokine delivery. Ann. NY Acad. Sci. 1182, 135–45 (2009).
  Medline CASGoogle Scholar
• 56. Vandenbroucke K, De Haard H, Beirnaert E et al. Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol. 3(1), 49 (2010).
  Medline CASGoogle Scholar
• 57. Hanson ML, Hixon JA, Li W et al. 112: Lactococcus lactis expressing IL-27: A potential therapeutic for inflammatory bowel disease. Cytokine 63(3), 269 (2013).
  Google Scholar
• 58. Chiabai MJ, Almeida JF, De Azevedo MGD et al. Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice. BMC Biotechnol. 19(1), 38 (2019).
  Medline CASGoogle Scholar
• 59. Esposito G, Pesce M, Seguella L et al. Engineered Lactobacillus paracasei producing palmitoylethanolamide (PEA) prevents colitis in mice. Int. J. Mol. Sci. 22(6), 2945 (2021).
  Medline CASGoogle Scholar
• 60. Yue Y-C, Yang B-Y, Lu J et al. Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway. Microb. Cell Factories 19, 1–12 (2020).
  MedlineGoogle Scholar
• 61. Nami Y, Abdullah N, Haghshenas B, Radiah D, Rosli R, Khosroushahi AY. Assessment of probiotic potential and anticancer activity of newly isolated vaginal bacterium Lactobacillus plantarum 5BL. Microbiol. Immunol. 58(9), 492–502 (2014).
  Medline CASGoogle Scholar
• 62. Dimitrovski D, Cencič A, Winkelhausen E, Langerholc T. Lactobacillus plantarum extracellular metabolites: In vitro assessment of probiotic effects on normal and cancerogenic human cells. Int. Dairy J. 39(2), 293–300 (2014).
  CASGoogle Scholar
• 63. Mobergslien A, Vasovic V, Mathiesen G et al. Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells. Human Vaccines Immunother. 11(11), 2664–2673 (2015).
  MedlineGoogle Scholar
• 64. Cho SS, Finocchiaro T. Handbook of prebiotics and probiotics ingredients: health benefits and food applications (1st Edition). CRC Press, USA (2009).
  Google Scholar
• 65. Uccello M, Malaguarnera G, Basile F et al. Potential role of probiotics on colorectal cancer prevention. BMC Surg. 12(1), S35 (2012).
  MedlineGoogle Scholar
• 66. Kruszewska D, Lan J, Lorca G, Yanagisawa N, Marklinder I, Ljungh Å. Selection of lactic acid bacteria as probiotic strains by in vitro tests. Microecol. Ther. 29, 37–49 (2002).
  CASGoogle Scholar
• 67. Walia S, Kamal R, Dhawan D, Kanwar S. Chemoprevention by probiotics during 1, 2-dimethylhydrazine-induced colon carcinogenesis in rats. Dig. Dis. Sci. 63(4), 900–909 (2018). • Investigates hemoprevention, which refers to the protective effect of probiotics in preventing colon cancer induced by 1,2-dimethylhydrazine in rats.
  Medline CASGoogle Scholar
• 68. Kahouli I, Tomaro-Duchesneau C, Prakash S. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. J. Med. Microbiol. 62(8), 1107–1123 (2013).
  Medline CASGoogle Scholar
• 69. Liong M-T. Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. Int. J. Mol. Sci. 9(5), 854–863 (2008).
  Medline CASGoogle Scholar
• 70. Bertkova I, Hijova E, Chmelarova A et al. The effect of probiotic microorganisms and bioactive compounds on chemically induced carcinogenesis in rats. Neoplasma 57(5), 422 (2010).
  Medline CASGoogle Scholar
• 71. An J, Ha E-M. Combination therapy of Lactobacillus plantarum supernatant and 5-fluouracil increases chemosensitivity in colorectal cancer cells. J. Microbiol. Biotechnol. 26(8), 1490–1503 (2016).
  Medline CASGoogle Scholar
• 72. Jaskulski IB, Uecker J, Bordini F et al. In vivo action of Lactococcus lactis subsp. lactis isolate (R7) with probiotic potential in the stabilization of cancer cells in the colorectal epithelium. Process Biochem. 91, 165–171 (2019).
  Google Scholar
• 73. De Leblanc ADM, Leblanc JG, Perdigon G et al. Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. J. Med. Microbiol. 57(1), 100–105 (2008).
  MedlineGoogle Scholar
• 74. Han KJ, Lee N-K, Park H, Paik H-D. Anticancer and anti-inflammatory activity of probiotic Lactococcus lactis NK34. J. Microbiol. Biotechnol. 25, 1697–1701 (2015). •• Describes the necessity of Lactococcus lactis as an anticancer probiotic.
  MedlineGoogle Scholar
• 75. Golestaneh M, Firoozrai M, Javid H, Hashemy SI. The substance P/neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells. Mol. Biol. Reports 49(6), 4893–4900 (2022).
  Medline CASGoogle Scholar
• 76. Bohlul E, Hasanlou F, Taromchi AH, Nadri S. TRAIL-expressing recombinant Lactococcus lactis induces apoptosis in human colon adenocarcinoma SW 480 and HCT 116 cells. J. Appl Microbiol. 126(5), 1558–1567 (2019).
  Medline CASGoogle Scholar
• 77. Zhang B, Li A, Zuo F et al. Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells. Microb. Cell Factories 15(1), 102 (2016).
  MedlineGoogle Scholar
• 78. Lee JC. Predicting the course of IBD: light at the end of the tunnel? Dig. Dis. 30(Suppl. 1), 95–99 (2012).
  MedlineGoogle Scholar
• 79. Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflammatory Bowel Diseases 16(9), 1598–1619 (2010).
  MedlineGoogle Scholar
• 80. Shale M, Kanfer E, Panaccione R, Ghosh S. Hepatosplenic T cell lymphoma in inflammatory bowel disease. Gut 57(12), 1639–1641 (2008).
  MedlineGoogle Scholar
• 81. Eaden J, Abrams K, Mayberry J. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48(4), 526–535 (2001).
  Medline CASGoogle Scholar
• 82. Lemoine L, Sugarbaker P, Van Der Speeten K. Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum. World J. Gastroenterol. 22(34), 7692 (2016).
  Medline CASGoogle Scholar
• 83. Sugarbaker PH. Improving oncologic outcomes for colorectal cancer at high risk for local-regional recurrence with novel surgical techniques. Expert Rev. Gastroenterol. Hepatol. 10(2), 205–213 (2016).
  Medline CASGoogle Scholar
• 84. Jess T, Winther K, Munkholm P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment. Pharmacol. Ther. 19(3), 287–293 (2004).
  Medline CASGoogle Scholar
• 85. Toscano M, De Grandi R, Pastorelli L, Vecchi M, Drago L. A consumer's guide for probiotics: 10 golden rules for a correct use. Digest. Liver Dis. 49(11), 1177–1184 (2017). • Illustrates the strategies and candidates of how-to consumer guides for probiotics.
  Google Scholar